Menopause

Reunion Neuroscience Partners with Seleni Institute on Effective Diagnosis and Treatment of Maternal Mental Health Disorders

Reunion to Sponsor Scholarships that will Train Healthcare Professionals on Maternal Mental Health Disorders, including Postpartum Depression Reunion’s Phase 2...

Maven Clinic Announces $125 Million Series F Round of Funding to Chart the Next Decade of Innovation in Women’s and Family Health

New funds will fuel growth of Maven's end-to-end platform, with a focus on scaling its fertility & family building program,...

Garmin recognizes innovative digital health solutions and celebrates 10th anniversary during 2024 Garmin Health Summit

Annual event highlights big research milestone and further advances benefits of smartwatch-enabled research OLATHE, Kan., Sept. 26, 2024 /PRNewswire/ --...

Carrot Fertility launches CarrotMatch for maternity, the first pregnancy navigation system to match members with the highest quality and most cost-effective providers for their unique needs

CarrotMatch eliminates frustrations and lowers costs while expanding support with virtual care teams, including doulas, midwives, grief counselors, nutritionists, and...

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Published data show that topical Sildenafil Cream, 3.6% was safe and well tolerated by women and their partners across 1,357...

SLATE Launches the World’s First 3-in-1 Rechargeable Electric Flosser Guaranteeing the Easiest, Most Effective At-Home Dental Cleaning in Under 60 Seconds

Invented by a dentist, Slate's non-toxic, reusable flosser is the only device proven to reach all areas of the mouth...

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Published data show that responses from 1-month and 24-hour recall patient reported outcome (PRO) instruments were similar and support that...

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting – Key SABRE Update Also Expected

Flo Health Secures More than $200M Investment from General Atlantic to Revolutionize Women’s Health; First Purely Digital Consumer Women’s Health App to Achieve Unicorn Status

Leading women's health app sets new benchmark in rapidly expanding femtech industry LONDON, July 30, 2024 /PRNewswire/ -- Flo Health, the...

error: Content is protected !!